| Laura D Lipold, MD | |
|
26900 Cedar Rd, Suite 22n, Beachwood, OH 44122-1191 | |
| (216) 839-3900 | |
| (216) 839-3931 |
| Full Name | Laura D Lipold |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 26900 Cedar Rd, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407810674 | NPI | - | NPPES |
| 2290211 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35075243D (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Hillcrest Hospital | Mayfield heights, OH | Hospital |
| South Pointe Hospital | Warrensville heights, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
| Menorah Park Center For Senior Living | 3577469444 | 187 |
News Archive
Omega Healthcare Investors, Inc. today announced that it has agreed to sell shares of its common stock having an aggregate offering price of $33.3 million pursuant to a terms agreement entered into under the equity distribution agreement, dated June 12, 2009, between the Company and BofA Merrill Lynch in connection with the company's previously reported $100 million Equity Shelf Program.
Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation.
More than 14-million Americans, with chronic or life altering diseases and cancer, can't afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That's why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.
› Verified 6 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Omega Healthcare Investors, Inc. today announced that it has agreed to sell shares of its common stock having an aggregate offering price of $33.3 million pursuant to a terms agreement entered into under the equity distribution agreement, dated June 12, 2009, between the Company and BofA Merrill Lynch in connection with the company's previously reported $100 million Equity Shelf Program.
Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation.
More than 14-million Americans, with chronic or life altering diseases and cancer, can't afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That's why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Laura D Lipold, MD 26900 Cedar Rd, Suite 22n, Beachwood, OH 44122-1191 Ph: (216) 839-3900 | Laura D Lipold, MD 26900 Cedar Rd, Suite 22n, Beachwood, OH 44122-1191 Ph: (216) 839-3900 |
News Archive
Omega Healthcare Investors, Inc. today announced that it has agreed to sell shares of its common stock having an aggregate offering price of $33.3 million pursuant to a terms agreement entered into under the equity distribution agreement, dated June 12, 2009, between the Company and BofA Merrill Lynch in connection with the company's previously reported $100 million Equity Shelf Program.
Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation.
More than 14-million Americans, with chronic or life altering diseases and cancer, can't afford the medication they need because of the high out-of-pocket costs associated with their insurance coverage. That's why the Chronic Disease Fund, a nonprofit organization, provides financial help to seriously ill Americans so they can get the medications they need to live without the fear of debt.
AtriCure, Inc., a medical device company and a leader in cardiac surgical ablation systems and systems for the exclusion of the left atrial appendage, announced initial patient enrollment in its DEEP AF feasibility trial. The first procedure was performed in a new, state-of-the-art hybrid room at Sentara Norfolk General Hospital in Norfolk, Virginia by Jonathan Philpott, M.D., Director of the Sentara Atrial Fibrillation Surgery Program, Ian Woollett, M.D., and John Onufer, M.D., Medical Director of Cardiac Electrophysiology.
› Verified 6 days ago
Dr. Barbara A Vizy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3690 Orange Pl, Suite # 230, Beachwood, OH 44122 Phone: 216-765-1180 Fax: 216-765-1163 | |
Dr. Richard M Garwood, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4200 Warrensville Center Rd, Suite 395, Beachwood, OH 44122 Phone: 216-491-7888 Fax: 216-491-7887 | |
Young Shin Kim, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 26900 Cedar Rd Ste 22n, Beachwood, OH 44122 Phone: 216-839-3000 | |
Anam Butt, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 26900 Cedar Rd, Beachwood, OH 44122 Phone: 216-839-3000 | |
Marie Ann Schaefer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 26900 Cedar Rd, Bd10, Beachwood, OH 44122 Phone: 216-839-3000 Fax: 216-839-3910 | |
Erin Donnelle Jeffers, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23214 Ranch Rd, Beachwood, OH 44122 Phone: 216-356-6550 | |
Dr. Joseph Chester Orzechowski, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 25700 Science Park Dr Ste 120, Beachwood, OH 44122 Phone: 216-672-0211 Fax: 978-645-6909 |